Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05.
Boige V et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2010